brdu (a7) monoclonal antibody Search Results


mouse anti brdu monoclonal ab  (Bioss)
91
Bioss mouse anti brdu monoclonal ab
Figure 4 The b-tubulin-III–positive neuron-like cells and the differentiation of endogenous progenitors in the sodium hyaluronate-CNTF group. (a) At 1 month PO in the sodium hyaluronate-CNTF group, many small and process-extending b-tubulin-III–positive neuron-like cells (shown by white arrows) were observed at the lesion edge of the host cord. (b) The b-tubulin-III–positive neuron-like cells were immunoreactive for NeuN (shown by white arrows). (c) At 1 month PO in the sodium hyaluronate-CNTF group, the b-tubulin-III–positive neuron-like cells (shown by white arrows) were detectable in the lesion area. (d) High magnification of the boxed area in panel (c). The b-tubulin-III–positive neuronal fiber (shown by white arrowhead) extended and the b-tubulin-III– positive neuron-like cell seemed to form cell contacts (shown by white arrow). (e–h) At 4 days PO in the sodium hyaluronate-CNTF group, <t>BrdU</t> (red) and DCX (green) double-positive cells were observed at the lesion edge of the host cord, with neuron-like appearance. The cells directed by white arrows in panel (g) are shown in panel (h). (i–l) At 11 days PO in the sodium hyaluronate-CNTF group, BrdU (red) and b-tubulin-III (green) double-positive cells were observed in the lesion area. The cell directed by the white arrow in panel (k) is shown in panel (l). The dotted lines indicate the boundary between the host and lesion area. Scale bars: (a, e–g), 100mm; (b, c and h), 50mm; d, 25 mm; (i–k), 75 mm. A full color version of this figure is available at the Spinal Cord journal online.
Mouse Anti Brdu Monoclonal Ab, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brdu+(a7)+monoclonal+antibody/BrdU+(A7)+Monoclonal+Antibody/pm24796451-46-49-54
Average 91 stars, based on 1 article reviews
mouse anti brdu monoclonal ab - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
brdu (a7) monoclonal antibody, abby fluor 555 conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, pe-cy7 conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, fitc conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, cy5 conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, rbitc conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, alexa fluor 594 conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, pe conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, biotin conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, apc-cy7 conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, abby fluor 647 conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier
brdu (a7) monoclonal antibody, abby fluor 680 conjugated  (Bioss)
N/A
Bromodeoxyuridine is a synthetic nucleoside that is an analogue of thymidine. BrdU is incorporated into DNA during S-phase of a cell cycle. It is commonly used in the detection of proliferating cells in living tissues
   Buy from Supplier

Image Search Results


Figure 4 The b-tubulin-III–positive neuron-like cells and the differentiation of endogenous progenitors in the sodium hyaluronate-CNTF group. (a) At 1 month PO in the sodium hyaluronate-CNTF group, many small and process-extending b-tubulin-III–positive neuron-like cells (shown by white arrows) were observed at the lesion edge of the host cord. (b) The b-tubulin-III–positive neuron-like cells were immunoreactive for NeuN (shown by white arrows). (c) At 1 month PO in the sodium hyaluronate-CNTF group, the b-tubulin-III–positive neuron-like cells (shown by white arrows) were detectable in the lesion area. (d) High magnification of the boxed area in panel (c). The b-tubulin-III–positive neuronal fiber (shown by white arrowhead) extended and the b-tubulin-III– positive neuron-like cell seemed to form cell contacts (shown by white arrow). (e–h) At 4 days PO in the sodium hyaluronate-CNTF group, BrdU (red) and DCX (green) double-positive cells were observed at the lesion edge of the host cord, with neuron-like appearance. The cells directed by white arrows in panel (g) are shown in panel (h). (i–l) At 11 days PO in the sodium hyaluronate-CNTF group, BrdU (red) and b-tubulin-III (green) double-positive cells were observed in the lesion area. The cell directed by the white arrow in panel (k) is shown in panel (l). The dotted lines indicate the boundary between the host and lesion area. Scale bars: (a, e–g), 100mm; (b, c and h), 50mm; d, 25 mm; (i–k), 75 mm. A full color version of this figure is available at the Spinal Cord journal online.

Journal: Spinal cord

Article Title: Sodium hyaluronate-CNTF gelatinous particles promote axonal growth, neurogenesis and functional recovery after spinal cord injury.

doi: 10.1038/sc.2014.54

Figure Lengend Snippet: Figure 4 The b-tubulin-III–positive neuron-like cells and the differentiation of endogenous progenitors in the sodium hyaluronate-CNTF group. (a) At 1 month PO in the sodium hyaluronate-CNTF group, many small and process-extending b-tubulin-III–positive neuron-like cells (shown by white arrows) were observed at the lesion edge of the host cord. (b) The b-tubulin-III–positive neuron-like cells were immunoreactive for NeuN (shown by white arrows). (c) At 1 month PO in the sodium hyaluronate-CNTF group, the b-tubulin-III–positive neuron-like cells (shown by white arrows) were detectable in the lesion area. (d) High magnification of the boxed area in panel (c). The b-tubulin-III–positive neuronal fiber (shown by white arrowhead) extended and the b-tubulin-III– positive neuron-like cell seemed to form cell contacts (shown by white arrow). (e–h) At 4 days PO in the sodium hyaluronate-CNTF group, BrdU (red) and DCX (green) double-positive cells were observed at the lesion edge of the host cord, with neuron-like appearance. The cells directed by white arrows in panel (g) are shown in panel (h). (i–l) At 11 days PO in the sodium hyaluronate-CNTF group, BrdU (red) and b-tubulin-III (green) double-positive cells were observed in the lesion area. The cell directed by the white arrow in panel (k) is shown in panel (l). The dotted lines indicate the boundary between the host and lesion area. Scale bars: (a, e–g), 100mm; (b, c and h), 50mm; d, 25 mm; (i–k), 75 mm. A full color version of this figure is available at the Spinal Cord journal online.

Article Snippet: Spinal cord sections were incubated in the following primary antibodies (Ab) at 4 1C for 48 h: mouse anti-neurofilament (Pan) monoclonal Ab (NF, 1:50, Zymed Laboratories, South San Francisco, CA, USA); rabbit anti-b-tubulin-III protein polyclonal Ab (btubulin-III, 1:100, Sigma); rabbit anti-glial fibrillary acidic protein polyclonal Ab (1:150, Zymed Laboratories); mouse anti-BrdU monoclonal Ab (1:70, Bioss, Woburn, MA, USA); and rabbit anti-doublecortin protein polyclonal Ab (DCX, 1:100, Abcam, Cambridge, MA, USA).

Techniques: